Kiora Pharmaceuticals Inc
KPRX· Nasdaq
KPRXKiora Pharmaceuticals Inc
Filed May 15, 2015 · 10-Q · 45 days after period end · 0001144204-15-031775
| Metric | Q1 2015 | Q1 2014 |
|---|---|---|
| Net Income | -$2.80M | -$902.89K |
| EPS Diluted | -$3.23 | -$0.47 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kiora Pharmaceuticals Inc · CIK 1372514 · Engraved from SEC EDGAR
ended Mar 31, 2015 · filed May 15, 2015 · 45 d after period end
